Clinical Trial Update: A Study To Investigate How The Body Handles Multiple Doses Of PF-0243873 And To Investigate The Effect Of PF-02413873 On Sex Hormone Levels In Healthy Young Women [Phase 1]

View source ↗

Summary

A Phase 1 trial completed to evaluate pharmacokinetics of PF-0243873 with multiple doses and to assess the effect of PF-02413873 on sex hormone levels in health…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• PF-02413873
• PF-0243873

Snippet

Sponsor: Pfizer | Conditions: Endometriosis | Phase 1 | Status: COMPLETED